Related Experiment Video
Updated: Jun 2, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
[Glycometabolism of patients with depression at first episode]
Qing-Chun Xia1, Gao-Hua Wang, Hai-Zhi Chen
1The Third People's Hospital of Huzhou, Huzhou 313000, China.
Objective:
To investigate glycometabolism of patients with depression at first episode.
Methods:
Oral glucose tolerance test (OGTT) was performed in 100 patients with depression at first episode and 50 healthy subjects; the levels of fast blood plasma insulin were also measured.
Result:
There were no statistically significant differences in fast blood plasma insulin levels and postprandial blood glucose levels at 0 h, 1 h and 3 h (P>0.05); the fasting blood glucose (FBS), postprandial blood glucose levels in 2 h and area under OGTT curve of depression patients were significantly higher than those of healthy controls. The frequency of impaired glucose tolerance (IGT) in depression patients was higher than that in controls (P<0.05).
Conclusion:
Depression patients at the first episode are abnormal in glycometabolism, which may have clinical implication.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Hypoglycemia and Glucagon
